Ikapharmindo Putramas Tbk. Total Assets
Ikapharmindo Putramas Tbk. total assets. Based on the latest financial reports, Ikapharmindo Putramas Tbk. (IKPM) holds total assets worth Rp476.89 Billion IDR (≈ $27.94 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see IKPM stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Ikapharmindo Putramas Tbk. (2022–2024)
Total assets of Ikapharmindo Putramas Tbk. from 2022 to 2024. This chart illustrates how Ikapharmindo Putramas Tbk.'s total assets have evolved over time, based on quarterly financial data. See Ikapharmindo Putramas Tbk. stock price for real-time trading data and today's change.
Ikapharmindo Putramas Tbk. - Asset Composition Analysis
Ikapharmindo Putramas Tbk. Total Assets Breakdown (December 2024)
Ikapharmindo Putramas Tbk. total assets breakdown as of December 2024. Ikapharmindo Putramas Tbk.'s total assets of Rp476.89 Billion consist of 68.6% current assets and 31.4% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 4.9% |
| Accounts Receivable | Rp256.36 Billion | 52.2% |
| Inventory | Rp51.76 Billion | 10.5% |
| Property, Plant & Equipment | Rp108.92 Billion | 22.2% |
| Intangible Assets | Rp14.57 Billion | 3.0% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2022–2024)
This chart illustrates how Ikapharmindo Putramas Tbk.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Ikapharmindo Putramas Tbk. working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ikapharmindo Putramas Tbk.'s current assets represent 68.6% of total assets in 2024, a decrease from 69.4% in 2022.
- Cash Position: Cash and equivalents constituted 4.9% of total assets in 2024, up from 2.8% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 52.2% of total assets.
Ikapharmindo Putramas Tbk. Competitors by Total Assets
Key competitors of Ikapharmindo Putramas Tbk. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.31 Billion |
|
Redcare Pharmacy NV
XETRA:RDC
|
Germany | €1.18 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.83 Billion |
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.13 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$347.87 Million |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
Ikapharmindo Putramas Tbk. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.51 | 1.53 | 1.53 |
| Quick Ratio | 1.25 | 1.25 | 1.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp107.86 Billion | Rp116.94 Billion | Rp116.94 Billion |
Ikapharmindo Putramas Tbk. - Advanced Valuation Insights
This section examines the relationship between Ikapharmindo Putramas Tbk.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.0% |
| Total Assets | Rp491.38 Billion |
| Market Capitalization | $13.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ikapharmindo Putramas Tbk.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Ikapharmindo Putramas Tbk.'s assets grew by 6.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Ikapharmindo Putramas Tbk. (2022–2024)
The table below shows the annual total assets of Ikapharmindo Putramas Tbk. from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp491.38 Billion ≈ $28.79 Million |
+6.04% |
| 2023-12-31 | Rp463.38 Billion ≈ $27.15 Million |
+19.56% |
| 2022-12-31 | Rp387.55 Billion ≈ $22.71 Million |
-- |
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and… Read more